Free Trial
NASDAQ:MGRM

Monogram Orthopaedics Q4 2023 Earnings Report

Monogram Orthopaedics logo
$5.80 +0.02 (+0.35%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$5.80 0.00 (-0.09%)
As of 08/29/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Monogram Orthopaedics EPS Results

Actual EPS
-$0.09
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Monogram Orthopaedics Revenue Results

Actual Revenue
$0.37 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Monogram Orthopaedics Announcement Details

Quarter
Q4 2023
Time
N/A
Conference Call Date
Friday, March 15, 2024
Conference Call Time
8:30AM ET

Upcoming Earnings

Monogram Orthopaedics' Q3 2025 earnings is scheduled for Thursday, November 13, 2025, with a conference call scheduled on Tuesday, November 18, 2025 at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Monogram Orthopaedics Earnings Headlines

Q3 EPS Forecast for Monogram Orthopaedics Reduced by Analyst
Monogram Orthopaedics Delays 10-Q Filing
Turn $1K into $50K with This DeFi Gem
Bitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it.tc pixel
Monogram Orthopaedics Updates on Zimmer Biomet Acquisition
Monogram Orthopaedics Initiates Mandatory Stock Conversion
See More Monogram Orthopaedics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Monogram Orthopaedics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Monogram Orthopaedics and other key companies, straight to your email.

About Monogram Orthopaedics

Monogram Orthopaedics (NASDAQ:MGRM), Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

View Monogram Orthopaedics Profile

More Earnings Resources from MarketBeat